openPR Logo
Press release

Buddy AI Labs Unveils Loody AI Companion Hub: AI Designed for Genuine Emotional Connection

10-24-2025 11:08 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: ABNewswire

Buddy AI Labs Unveils Loody AI Companion Hub: AI Designed

Image: https://www.abnewswire.com/upload/2025/10/53eb5594a29e04ba64bbe186b4b0eedc.jpg

Buddy AI Labs, Inc. today announced the launch of Loody AI Companion Hub, a revolutionary visual AI device set to redefine digital companionship. Loody is the first AI designed from the ground up to foster deep, continuous emotional connections by remembering past conversations, understanding user emotions, and offering fully customizable character interactions.

Image: https://www.abnewswire.com/upload/2025/10/36eefa9ea5a09d14027b9cf97f924d22.jpg

Unlike traditional AI assistants that offer transactional responses, Loody is capable of providing a partner who genuinely gets to know you. Utilizing advanced multi-modal sensor technology, Loody perceives user emotions through smiles, sighs, and voice nuances, enabling incredibly lifelike and empathetic interactions.

Image: https://www.abnewswire.com/upload/2025/10/43e52d6382a5e89e7fea1de7778545da.jpg

Key Features of the Loody AI Companion Hub include:

- AI Character Generator: Users can provide 1-5 image files to generate a perfect AI companion, designed for users, by users. This platform allows consumers to simply drag and drop their favorite character drawings to generate interactive characters with unique expressions and voices to meet their lifestyle.

- Artificial Emotional Intelligence: Utilization of visual and auditory multi-modal sensor technology allows Loody to recognize and respond to user expressions and vocal tones, fostering empathetic and natural conversations.

- A Connection That Remembers: Built with a sophisticated memory engine, Loody remembers past conversations, personal stories, and preferences, allowing relationships to deepen and evolve over time.

- Fully Customizable Character: Users can personalize their AI companion's appearance, voice, and even its core personality traits and dialogue style.

- Lifelike Visual Interaction: An 8.68" hyper-realistic display brings characters to life with fluid animations and expressions, creating an immersive "video call" experience with your companion.

- Choice of Advanced AI Engines: Loody offers flexibility, allowing users to select their preferred underlying AI model from leading providers such as OpenAI, Google Gemini, Anthropic Claude, and xAI Grok, ensuring powerful and versatile interactions.

- Smart Home Integration: Loody seamlessly connects with popular smart home ecosystems like Google Home, Amazon Alexa, and LG ThinQ, allowing users to control their environment, be accompanied by music in the background that matches the mood, and receive updates while interacting with their companion.

Image: https://www.abnewswire.com/upload/2025/10/c2402d2ed8163760ca73b9b2d741a795.jpg

The Loody AI Companion Hub is set to launch on Kickstarter in November. Limited number of backers will have the opportunity to secure their Loody at a significant discount for being early adopters.

About Buddy AI Labs, Inc.:

Buddy AI Labs, Inc. is a pioneering technology company dedicated to developing cutting-edge artificial intelligence solutions that enhance human connection and well-being. With a focus on emotional intelligence and user-centric design, Buddy AI Labs aims to create AI companions that enrich daily life and foster meaningful relationships.

Media Contact
Company Name: Buddy AI Labs, Inc.
Contact Person: Media Relations
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=buddy-ai-labs-unveils-loody-ai-companion-hub-ai-designed-for-genuine-emotional-connection]
Country: United States
Website: http://www.loody-companionhub.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Buddy AI Labs Unveils Loody AI Companion Hub: AI Designed for Genuine Emotional Connection here

News-ID: 4238738 • Views:

More Releases from ABNewswire

JCFLOW Unveils Bold New 15mm Silicone Printed Beads Collection for DIY Enthusiasts
JCFLOW Unveils Bold New 15mm Silicone Printed Beads Collection for DIY Enthusias …
Building on its recent product expansion, JCFLOW today officially launched a dynamic line of 15mm silicone printed beads, designed to inspire creativity for DIY crafters and small business artisans alike. Known for its high-quality silicone beads, JCFLOW continues to set the standard for innovation in the crafting industry, offering beads that are vibrant, durable, and versatile enough to elevate any jewelry or accessory project. The new 15mm collection [https://jcflowbeads.com/collections/15mm-silicone-printed-beads] includes printed
Global Neurofibromatosis Type 2 Pipeline Expands With 5+ Companies Advancing 5+ Therapies, Reveals DelveInsight's Clinical and Developmental Analysis
Global Neurofibromatosis Type 2 Pipeline Expands With 5+ Companies Advancing 5+ …
Leading Neurofibromatosis Type 2 Companies include Recursion Pharmaceuticals, Vivace Therapeutics, Healx Limited, SpringWorks Therapeutics, AstraZeneca, Fosun Pharmaceutical, NFlection Therapeutics, and several other innovators. The global Neurofibromatosis Type 2 (NF2) therapeutic pipeline is witnessing steady expansion, driven by growing research momentum and increased investment in rare neurological disorders. According to DelveInsight's latest analysis, more than five pharmaceutical and biotechnology companies are actively advancing over five therapeutic candidates aimed at addressing the unmet
Chronic Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Domain | DelveInsight
Chronic Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 20+ Key Pha …
DelveInsight's, "Chronic Myeloid Leukaemia Pipeline Insight, 2026" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Chronic Myeloid Leukaemia pipeline landscape. It covers the Chronic Myeloid Leukemia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Chronic Myeloid Leukemia pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the
Tendinopathy Market Size in the 7MM is Project to Grow with a Significant CAGR by 2034, estimates DelveInsight
Tendinopathy Market Size in the 7MM is Project to Grow with a Significant CAGR b …
DelveInsight's "Tendonitis Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Tendonitis, historical and forecasted epidemiology as well as the Tendonitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Discover Key Insights into the Tendinopathy Market with DelveInsight's In-Depth Report @ Tendinopathy Market Size [https://www.delveinsight.com/sample-request/tendinopathy-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr] Key Takeaways from the Tendonitis Market Research Report * On January 08, 2026- Laboratorios Silanes S.A.

All 5 Releases